

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 6.91857180 |
| 2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.84510066 |
| 3 | lateral sprouting from an epithelium (GO:0060601) | 5.43340272 |
| 4 | sarcomere organization (GO:0045214) | 5.11954701 |
| 5 | desmosome organization (GO:0002934) | 5.02600399 |
| 6 | establishment of skin barrier (GO:0061436) | 4.97700191 |
| 7 | otic vesicle formation (GO:0030916) | 4.81967837 |
| 8 | * 4-hydroxyproline metabolic process (GO:0019471) | 4.62504455 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.60005452 |
| 10 | glomerular basement membrane development (GO:0032836) | 4.59867265 |
| 11 | negative regulation of protein localization to cell surface (GO:2000009) | 4.46943478 |
| 12 | keratinocyte proliferation (GO:0043616) | 4.37100960 |
| 13 | regulation of water loss via skin (GO:0033561) | 4.27870459 |
| 14 | actin-myosin filament sliding (GO:0033275) | 4.07364685 |
| 15 | muscle filament sliding (GO:0030049) | 4.07364685 |
| 16 | cell-substrate junction assembly (GO:0007044) | 4.03690980 |
| 17 | regulation of skeletal muscle contraction (GO:0014819) | 3.81765201 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.74013437 |
| 19 | limb bud formation (GO:0060174) | 3.70652362 |
| 20 | multicellular organismal water homeostasis (GO:0050891) | 3.67709090 |
| 21 | hair cycle (GO:0042633) | 3.65312825 |
| 22 | molting cycle (GO:0042303) | 3.65312825 |
| 23 | apoptotic process involved in morphogenesis (GO:0060561) | 3.54456429 |
| 24 | plasma membrane repair (GO:0001778) | 3.52272186 |
| 25 | pentose-phosphate shunt (GO:0006098) | 3.52011892 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.41856072 |
| 27 | embryonic camera-type eye development (GO:0031076) | 3.41083455 |
| 28 | cardiac myofibril assembly (GO:0055003) | 3.40512244 |
| 29 | positive regulation of histone deacetylation (GO:0031065) | 3.37427499 |
| 30 | actin-mediated cell contraction (GO:0070252) | 3.32955200 |
| 31 | muscle cell fate commitment (GO:0042693) | 3.32268151 |
| 32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.29095456 |
| 33 | mesonephros development (GO:0001823) | 3.24882092 |
| 34 | gap junction assembly (GO:0016264) | 3.24787485 |
| 35 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.23641385 |
| 36 | tricarboxylic acid cycle (GO:0006099) | 3.22588557 |
| 37 | epithelial cell-cell adhesion (GO:0090136) | 3.22560441 |
| 38 | epidermal cell differentiation (GO:0009913) | 3.17826287 |
| 39 | peptide cross-linking (GO:0018149) | 3.17640760 |
| 40 | regulation of keratinocyte proliferation (GO:0010837) | 3.16328585 |
| 41 | glomerular filtration (GO:0003094) | 3.15777951 |
| 42 | interferon-gamma secretion (GO:0072643) | 3.13929672 |
| 43 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.12879684 |
| 44 | NADPH regeneration (GO:0006740) | 3.12049845 |
| 45 | striated muscle hypertrophy (GO:0014897) | 3.11453049 |
| 46 | intermediate filament organization (GO:0045109) | 3.11276019 |
| 47 | lung epithelium development (GO:0060428) | 3.09859680 |
| 48 | peripheral nervous system axon ensheathment (GO:0032292) | 3.09602420 |
| 49 | myelination in peripheral nervous system (GO:0022011) | 3.09602420 |
| 50 | growth hormone receptor signaling pathway (GO:0060396) | 3.08894626 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08528622 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08528622 |
| 53 | positive regulation of focal adhesion assembly (GO:0051894) | 3.07988994 |
| 54 | positive regulation of cell junction assembly (GO:1901890) | 3.07988994 |
| 55 | water homeostasis (GO:0030104) | 3.05795226 |
| 56 | regulation of protein localization to cell surface (GO:2000008) | 3.05278719 |
| 57 | regulation of bile acid biosynthetic process (GO:0070857) | 3.04382522 |
| 58 | myofibril assembly (GO:0030239) | 3.03501863 |
| 59 | actomyosin structure organization (GO:0031032) | 3.02769518 |
| 60 | bicarbonate transport (GO:0015701) | 3.02449283 |
| 61 | glycolytic process (GO:0006096) | 2.96278374 |
| 62 | 2-oxoglutarate metabolic process (GO:0006103) | 2.94818635 |
| 63 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.94304057 |
| 64 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.93295065 |
| 65 | epidermis development (GO:0008544) | 2.93151808 |
| 66 | cardiac muscle contraction (GO:0060048) | 2.90551417 |
| 67 | cardiac muscle cell action potential (GO:0086001) | 2.90236718 |
| 68 | heart trabecula formation (GO:0060347) | 2.89148254 |
| 69 | actin filament-based movement (GO:0030048) | 2.88337938 |
| 70 | organ formation (GO:0048645) | 2.86767266 |
| 71 | positive regulation of glomerulus development (GO:0090193) | 2.86588039 |
| 72 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.85753147 |
| 73 | cardiac muscle cell development (GO:0055013) | 2.85374205 |
| 74 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.83876768 |
| 75 | renal filtration (GO:0097205) | 2.83803936 |
| 76 | glucose 6-phosphate metabolic process (GO:0051156) | 2.83643220 |
| 77 | regulation of glomerulus development (GO:0090192) | 2.82941672 |
| 78 | chemical homeostasis within a tissue (GO:0048875) | 2.82254521 |
| 79 | positive regulation of digestive system process (GO:0060456) | 2.82139600 |
| 80 | prostaglandin biosynthetic process (GO:0001516) | 2.81178144 |
| 81 | prostanoid biosynthetic process (GO:0046457) | 2.81178144 |
| 82 | keratinization (GO:0031424) | 2.80315463 |
| 83 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.79546422 |
| 84 | positive regulation of adherens junction organization (GO:1903393) | 2.78725638 |
| 85 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78540805 |
| 86 | carnitine shuttle (GO:0006853) | 2.77714326 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 2.77264243 |
| 88 | glucose catabolic process (GO:0006007) | 2.76852107 |
| 89 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.76336875 |
| 90 | cardiac cell development (GO:0055006) | 2.76319312 |
| 91 | skeletal muscle adaptation (GO:0043501) | 2.75866426 |
| 92 | surfactant homeostasis (GO:0043129) | 2.75650683 |
| 93 | response to muscle activity (GO:0014850) | 2.75506404 |
| 94 | skin morphogenesis (GO:0043589) | 2.75301382 |
| 95 | radial glial cell differentiation (GO:0060019) | 2.74393219 |
| 96 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.73922606 |
| 97 | T cell apoptotic process (GO:0070231) | 2.73816295 |
| 98 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.73057017 |
| 99 | hepatocyte apoptotic process (GO:0097284) | 2.72691221 |
| 100 | sodium ion export (GO:0071436) | 2.70070434 |
| 101 | negative regulation of heart growth (GO:0061117) | 2.69596289 |
| 102 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.69596289 |
| 103 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.69533003 |
| 104 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.68071282 |
| 105 | cell communication by electrical coupling (GO:0010644) | 2.67495700 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 2.67017948 |
| 107 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.66436602 |
| 108 | defense response to fungus (GO:0050832) | 2.64794767 |
| 109 | cardiac conduction (GO:0061337) | 2.64764181 |
| 110 | fructose metabolic process (GO:0006000) | 2.64218788 |
| 111 | cranial suture morphogenesis (GO:0060363) | 2.63901149 |
| 112 | creatine metabolic process (GO:0006600) | 2.63865166 |
| 113 | lung vasculature development (GO:0060426) | 2.63404558 |
| 114 | tricarboxylic acid metabolic process (GO:0072350) | 2.63253488 |
| 115 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.63244578 |
| 116 | maternal placenta development (GO:0001893) | 2.62815047 |
| 117 | decidualization (GO:0046697) | 2.62763434 |
| 118 | kidney morphogenesis (GO:0060993) | 2.62355841 |
| 119 | organ induction (GO:0001759) | 2.61127038 |
| 120 | regulation of cardioblast differentiation (GO:0051890) | 2.60433290 |
| 121 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.60030936 |
| 122 | focal adhesion assembly (GO:0048041) | 2.59581545 |
| 123 | cell-substrate adherens junction assembly (GO:0007045) | 2.59581545 |
| 124 | trophectodermal cell differentiation (GO:0001829) | 2.58598832 |
| 125 | regulation of actin filament-based movement (GO:1903115) | 2.57701558 |
| 126 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.57699586 |
| 127 | striated muscle atrophy (GO:0014891) | 2.56614376 |
| 128 | regulation of p38MAPK cascade (GO:1900744) | 2.56553288 |
| 129 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.56134970 |
| 130 | striated muscle contraction (GO:0006941) | 2.55299508 |
| 131 | muscle hypertrophy (GO:0014896) | 2.54486643 |
| 132 | valine metabolic process (GO:0006573) | 2.54300518 |
| 133 | gas transport (GO:0015669) | 2.52855928 |
| 134 | protein localization to cell surface (GO:0034394) | 2.51596104 |
| 135 | pyruvate metabolic process (GO:0006090) | 2.51250546 |
| 136 | cellular response to growth hormone stimulus (GO:0071378) | 2.51179203 |
| 137 | cell communication involved in cardiac conduction (GO:0086065) | 2.50948674 |
| 138 | type B pancreatic cell proliferation (GO:0044342) | 2.49245052 |
| 139 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.48267476 |
| 140 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.48253961 |
| 141 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.48091623 |
| 142 | fatty acid transmembrane transport (GO:1902001) | 2.47032875 |
| 143 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.46703898 |
| 144 | ventricular cardiac muscle cell development (GO:0055015) | 2.45489257 |
| 145 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.45468136 |
| 146 | negative regulation of cell size (GO:0045792) | 2.45173872 |
| 147 | low-density lipoprotein particle clearance (GO:0034383) | 2.44127934 |
| 148 | regulation of cofactor metabolic process (GO:0051193) | 2.43809558 |
| 149 | regulation of coenzyme metabolic process (GO:0051196) | 2.43809558 |
| 150 | * protein hydroxylation (GO:0018126) | 2.43678123 |
| 151 | positive regulation of p38MAPK cascade (GO:1900745) | 2.43390035 |
| 152 | brown fat cell differentiation (GO:0050873) | 2.43054971 |
| 153 | regulation of sequestering of triglyceride (GO:0010889) | 2.42688861 |
| 154 | hypotonic response (GO:0006971) | 2.42440092 |
| 155 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.41877150 |
| 156 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.40744952 |
| 157 | mesodermal cell differentiation (GO:0048333) | 2.40295737 |
| 158 | positive regulation of vascular permeability (GO:0043117) | 2.39959812 |
| 159 | muscle tissue morphogenesis (GO:0060415) | 2.39603996 |
| 160 | negative regulation of fatty acid transport (GO:2000192) | 2.39418732 |
| 161 | lymphocyte apoptotic process (GO:0070227) | 2.38789555 |
| 162 | atrioventricular valve morphogenesis (GO:0003181) | 2.37224182 |
| 163 | positive regulation of protein deacetylation (GO:0090312) | 2.37020512 |
| 164 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.36811717 |
| 165 | epithelial structure maintenance (GO:0010669) | 2.36463308 |
| 166 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.36344044 |
| 167 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36286622 |
| 168 | regulation of translational fidelity (GO:0006450) | 2.35267859 |
| 169 | adherens junction assembly (GO:0034333) | 2.35252874 |
| 170 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.32947321 |
| 171 | keratinocyte differentiation (GO:0030216) | 2.30664952 |
| 172 | apoptotic process involved in development (GO:1902742) | 2.30582595 |
| 173 | lysine metabolic process (GO:0006553) | 2.30305373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.53412648 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.96512594 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.86777268 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.44237549 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.96195867 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60868519 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.59344875 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.56210516 |
| 9 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.51345308 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35460398 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.32759234 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.21347136 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.16245900 |
| 14 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.14323664 |
| 15 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.12189898 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.10930645 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04145056 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01641550 |
| 19 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.97266044 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94588107 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.94465447 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91264416 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.91147930 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.88376221 |
| 25 | ATF3_27146783_Chip-Seq_COLON_Human | 1.85060174 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.84760237 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83292064 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82941451 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82748397 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78919837 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75414758 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74270919 |
| 33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69734054 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67996252 |
| 35 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66034049 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.64858282 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61121814 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.59925029 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58597776 |
| 40 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57411622 |
| 41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57147862 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.55971603 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54849460 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54849460 |
| 45 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.54288656 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.54288656 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.54288656 |
| 48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.51133011 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.50505732 |
| 50 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50259040 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.49918694 |
| 52 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46920617 |
| 53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45653765 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44587176 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.43987559 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42969921 |
| 57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.42419255 |
| 58 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41425848 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41223322 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41087178 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40838533 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40032288 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39115174 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38902080 |
| 65 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.38406480 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.38336738 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.38336738 |
| 68 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37660536 |
| 69 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37530625 |
| 70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36132353 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36127942 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35512313 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35154483 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34356782 |
| 75 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.32286182 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32227253 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30038540 |
| 78 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29555326 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27826042 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27701164 |
| 81 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.25821198 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25358783 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24883244 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23183182 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21734995 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21358075 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20439586 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20388174 |
| 89 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19795769 |
| 90 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19286519 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19040007 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18816930 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16189194 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15413450 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15336608 |
| 96 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15192665 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14417811 |
| 98 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.13788357 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13781285 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13600046 |
| 101 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13236580 |
| 102 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13236580 |
| 103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12978886 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12271288 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11732848 |
| 106 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.10448048 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10059571 |
| 108 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.09474058 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09165741 |
| 110 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08388742 |
| 111 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07455060 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07395569 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07204828 |
| 114 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06816781 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06632402 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06354722 |
| 117 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.06346438 |
| 118 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04915938 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04611696 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.04397071 |
| 121 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04091658 |
| 122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02578943 |
| 123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98906063 |
| 124 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98698024 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98603829 |
| 126 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98479468 |
| 127 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97582928 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96769975 |
| 129 | MYB_26560356_Chip-Seq_TH2_Human | 0.96557098 |
| 130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95372390 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94122580 |
| 132 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93692931 |
| 133 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92244840 |
| 134 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92121103 |
| 135 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.91952110 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91129497 |
| 137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90682451 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89998736 |
| 139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89804414 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89654374 |
| 141 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89337003 |
| 142 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.88964323 |
| 143 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88961220 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88783736 |
| 145 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.88760765 |
| 146 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.88075164 |
| 147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87196286 |
| 148 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.86729542 |
| 149 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86450042 |
| 150 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.86154586 |
| 151 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86026859 |
| 152 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85859200 |
| 153 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85335930 |
| 154 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85217948 |
| 155 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85140566 |
| 156 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84915867 |
| 157 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82929605 |
| 158 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82174874 |
| 159 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82151145 |
| 160 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82031332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005377_hearing/vestibular/ear_phenot | 4.84429435 |
| 2 | MP0003878_abnormal_ear_physiology | 4.84429435 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.45733574 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.75906840 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.31836916 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.04573042 |
| 7 | MP0003941_abnormal_skin_development | 2.65956763 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.61639013 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.50660714 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.49353827 |
| 11 | MP0000751_myopathy | 2.40176841 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.35951826 |
| 13 | MP0000566_synostosis | 2.33665139 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.28021129 |
| 15 | MP0005330_cardiomyopathy | 2.22616118 |
| 16 | MP0003646_muscle_fatigue | 2.13146250 |
| 17 | MP0004885_abnormal_endolymph | 2.11479662 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.11266593 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.11086137 |
| 20 | MP0001849_ear_inflammation | 2.07131595 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.05088216 |
| 22 | MP0002796_impaired_skin_barrier | 1.99911776 |
| 23 | MP0002102_abnormal_ear_morphology | 1.96961317 |
| 24 | MP0010630_abnormal_cardiac_muscle | 1.90770450 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.87555437 |
| 26 | MP0005248_abnormal_Harderian_gland | 1.77807859 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.68997753 |
| 28 | MP0002254_reproductive_system_inflammat | 1.68884695 |
| 29 | MP0000749_muscle_degeneration | 1.67778550 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.67475377 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.66087809 |
| 32 | MP0004130_abnormal_muscle_cell | 1.64923326 |
| 33 | MP0002106_abnormal_muscle_physiology | 1.64004531 |
| 34 | MP0005360_urolithiasis | 1.63105384 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.59161917 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.55368121 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.55368121 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.53357468 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.53255385 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49272155 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.49057917 |
| 42 | MP0005501_abnormal_skin_physiology | 1.45601901 |
| 43 | MP0001485_abnormal_pinna_reflex | 1.45230410 |
| 44 | MP0005409_darkened_coat_color | 1.40331740 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.38845589 |
| 46 | MP0002269_muscular_atrophy | 1.38482687 |
| 47 | MP0002060_abnormal_skin_morphology | 1.37924095 |
| 48 | MP0005275_abnormal_skin_tensile | 1.37294255 |
| 49 | MP0005023_abnormal_wound_healing | 1.35371527 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.34929473 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.34548747 |
| 52 | MP0005620_abnormal_muscle_contractility | 1.33486197 |
| 53 | MP0004272_abnormal_basement_membrane | 1.32183455 |
| 54 | MP0000733_abnormal_muscle_development | 1.31289236 |
| 55 | MP0003828_pulmonary_edema | 1.30406052 |
| 56 | MP0004484_altered_response_of | 1.30215853 |
| 57 | MP0003866_abnormal_defecation | 1.28665844 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.28347986 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.28325814 |
| 60 | MP0001216_abnormal_epidermal_layer | 1.26182538 |
| 61 | MP0009840_abnormal_foam_cell | 1.24335324 |
| 62 | MP0003303_peritoneal_inflammation | 1.23046371 |
| 63 | MP0004947_skin_inflammation | 1.22921860 |
| 64 | MP0000759_abnormal_skeletal_muscle | 1.21994451 |
| 65 | MP0004085_abnormal_heartbeat | 1.21215729 |
| 66 | MP0005369_muscle_phenotype | 1.18232322 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.18227107 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.17658261 |
| 69 | MP0000747_muscle_weakness | 1.17440415 |
| 70 | MP0008004_abnormal_stomach_pH | 1.16717468 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.16539109 |
| 72 | MP0000858_altered_metastatic_potential | 1.15816556 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.13726402 |
| 74 | MP0009379_abnormal_foot_pigmentation | 1.12745954 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 1.11967570 |
| 76 | MP0006138_congestive_heart_failure | 1.10388236 |
| 77 | MP0001881_abnormal_mammary_gland | 1.08184237 |
| 78 | MP0003119_abnormal_digestive_system | 1.06625625 |
| 79 | MP0003436_decreased_susceptibility_to | 1.06265854 |
| 80 | MP0000647_abnormal_sebaceous_gland | 1.04715025 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.02153834 |
| 82 | MP0000467_abnormal_esophagus_morphology | 1.01055853 |
| 83 | MP0001756_abnormal_urination | 0.98043105 |
| 84 | MP0004510_myositis | 0.95752789 |
| 85 | MP0003938_abnormal_ear_development | 0.95092290 |
| 86 | MP0003045_fibrosis | 0.94644980 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.94114428 |
| 88 | MP0000537_abnormal_urethra_morphology | 0.93041598 |
| 89 | MP0000579_abnormal_nail_morphology | 0.92026422 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.91816220 |
| 91 | MP0000343_altered_response_to | 0.90352152 |
| 92 | MP0002132_abnormal_respiratory_system | 0.90023228 |
| 93 | MP0004043_abnormal_pH_regulation | 0.89846978 |
| 94 | MP0000627_abnormal_mammary_gland | 0.89758286 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.89431888 |
| 96 | MP0000377_abnormal_hair_follicle | 0.88453384 |
| 97 | MP0005165_increased_susceptibility_to | 0.86357829 |
| 98 | MP0004270_analgesia | 0.85355066 |
| 99 | MP0009053_abnormal_anal_canal | 0.84765290 |
| 100 | MP0001853_heart_inflammation | 0.84494528 |
| 101 | MP0000266_abnormal_heart_morphology | 0.84056255 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.83957289 |
| 103 | MP0002933_joint_inflammation | 0.83153356 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.83033411 |
| 105 | MP0009931_abnormal_skin_appearance | 0.82388775 |
| 106 | MP0005085_abnormal_gallbladder_physiolo | 0.80808178 |
| 107 | MP0000383_abnormal_hair_follicle | 0.80340567 |
| 108 | MP0000026_abnormal_inner_ear | 0.80262799 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.79717903 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.79486147 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.78204091 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.78187331 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 0.77629222 |
| 114 | MP0003984_embryonic_growth_retardation | 0.77610499 |
| 115 | MP0002697_abnormal_eye_size | 0.76816416 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.76361467 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.76237925 |
| 118 | MP0005365_abnormal_bile_salt | 0.75794511 |
| 119 | MP0002396_abnormal_hematopoietic_system | 0.74863624 |
| 120 | MP0000490_abnormal_crypts_of | 0.74105094 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.73960992 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.73601388 |
| 123 | MP0002111_abnormal_tail_morphology | 0.72447878 |
| 124 | MP0010329_abnormal_lipoprotein_level | 0.71919506 |
| 125 | MP0002925_abnormal_cardiovascular_devel | 0.70775136 |
| 126 | MP0010771_integument_phenotype | 0.70674645 |
| 127 | MP0003448_altered_tumor_morphology | 0.70574530 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.70422392 |
| 129 | MP0002233_abnormal_nose_morphology | 0.69553929 |
| 130 | MP0005670_abnormal_white_adipose | 0.69495884 |
| 131 | * MP0000230_abnormal_systemic_arterial | 0.69175842 |
| 132 | MP0002971_abnormal_brown_adipose | 0.69105805 |
| 133 | MP0003950_abnormal_plasma_membrane | 0.68764317 |
| 134 | MP0000609_abnormal_liver_physiology | 0.68327715 |
| 135 | MP0004019_abnormal_vitamin_homeostasis | 0.68140099 |
| 136 | MP0002295_abnormal_pulmonary_circulatio | 0.68115508 |
| 137 | MP0010307_abnormal_tumor_latency | 0.66763324 |
| 138 | MP0002086_abnormal_extraembryonic_tissu | 0.65883145 |
| 139 | MP0001188_hyperpigmentation | 0.64829048 |
| 140 | MP0005332_abnormal_amino_acid | 0.64539278 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.64088634 |
| 142 | MP0000534_abnormal_ureter_morphology | 0.63689621 |
| 143 | MP0003942_abnormal_urinary_system | 0.60274146 |
| 144 | MP0008438_abnormal_cutaneous_collagen | 0.59848023 |
| 145 | MP0004742_abnormal_vestibular_system | 0.56851909 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.56230848 |
| 147 | MP0003890_abnormal_embryonic-extraembry | 0.54295995 |
| 148 | MP0003718_maternal_effect | 0.53279871 |
| 149 | MP0002108_abnormal_muscle_morphology | 0.52857890 |
| 150 | MP0003136_yellow_coat_color | 0.52615370 |
| 151 | MP0001784_abnormal_fluid_regulation | 0.50447279 |
| 152 | MP0003115_abnormal_respiratory_system | 0.49421230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.48172411 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.47107420 |
| 3 | Abnormality of nail color (HP:0100643) | 5.23024485 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.93419554 |
| 5 | Sudden death (HP:0001699) | 4.39103017 |
| 6 | Myoglobinuria (HP:0002913) | 4.38509776 |
| 7 | Milia (HP:0001056) | 4.31749083 |
| 8 | Aplasia involving bones of the extremities (HP:0009825) | 4.12028241 |
| 9 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.12028241 |
| 10 | Aplasia of the phalanges of the hand (HP:0009802) | 4.12028241 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.11414964 |
| 12 | Corneal erosion (HP:0200020) | 3.89439478 |
| 13 | Rhabdomyolysis (HP:0003201) | 3.84518366 |
| 14 | Onycholysis (HP:0001806) | 3.84393368 |
| 15 | Increased connective tissue (HP:0009025) | 3.81770554 |
| 16 | Popliteal pterygium (HP:0009756) | 3.76896671 |
| 17 | Abnormality of the salivary glands (HP:0010286) | 3.73350258 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.70390299 |
| 19 | Palmoplantar hyperkeratosis (HP:0000972) | 3.68709877 |
| 20 | Palmar hyperkeratosis (HP:0010765) | 3.54515216 |
| 21 | Exercise-induced myalgia (HP:0003738) | 3.54255839 |
| 22 | Abnormal auditory evoked potentials (HP:0006958) | 3.52133939 |
| 23 | Fragile nails (HP:0001808) | 3.48684661 |
| 24 | Atrophic scars (HP:0001075) | 3.43339608 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 3.38672154 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 3.30117123 |
| 27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.24805386 |
| 28 | Partial duplication of thumb phalanx (HP:0009944) | 3.24797747 |
| 29 | Erythroderma (HP:0001019) | 3.18031190 |
| 30 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.16982510 |
| 31 | Thick nail (HP:0001805) | 3.06534230 |
| 32 | Ependymoma (HP:0002888) | 3.04216015 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 2.96788423 |
| 34 | Lipoatrophy (HP:0100578) | 2.93614134 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.91996543 |
| 36 | Subaortic stenosis (HP:0001682) | 2.91996543 |
| 37 | Recurrent corneal erosions (HP:0000495) | 2.90435455 |
| 38 | Oral leukoplakia (HP:0002745) | 2.88086762 |
| 39 | EMG: myopathic abnormalities (HP:0003458) | 2.87405386 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 2.84640827 |
| 41 | Difficulty running (HP:0009046) | 2.82559032 |
| 42 | Nemaline bodies (HP:0003798) | 2.82329829 |
| 43 | Glomerulonephritis (HP:0000099) | 2.79943222 |
| 44 | Hypotrichosis (HP:0001006) | 2.76386587 |
| 45 | Pili torti (HP:0003777) | 2.75697636 |
| 46 | Plantar hyperkeratosis (HP:0007556) | 2.74769310 |
| 47 | Axonal loss (HP:0003447) | 2.71073613 |
| 48 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.68158118 |
| 49 | Partial duplication of the phalanx of hand (HP:0009999) | 2.67800452 |
| 50 | Erythema (HP:0010783) | 2.65169583 |
| 51 | Palpitations (HP:0001962) | 2.64523137 |
| 52 | Alacrima (HP:0000522) | 2.62873623 |
| 53 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.60223542 |
| 54 | Abnormality of the calf musculature (HP:0001430) | 2.59906345 |
| 55 | Decreased lacrimation (HP:0000633) | 2.58206693 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.53649091 |
| 57 | Abnormality of placental membranes (HP:0011409) | 2.50489916 |
| 58 | Amniotic constriction ring (HP:0009775) | 2.50489916 |
| 59 | Atrial fibrillation (HP:0005110) | 2.49794562 |
| 60 | Corneal dystrophy (HP:0001131) | 2.48084601 |
| 61 | Ulnar deviation of the wrist (HP:0003049) | 2.47044079 |
| 62 | Limb-girdle muscle atrophy (HP:0003797) | 2.43641165 |
| 63 | Dilated cardiomyopathy (HP:0001644) | 2.42735247 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.41764397 |
| 65 | Primary atrial arrhythmia (HP:0001692) | 2.38478429 |
| 66 | Aplasia of the musculature (HP:0100854) | 2.34838167 |
| 67 | Myopathic facies (HP:0002058) | 2.34061065 |
| 68 | Ventricular arrhythmia (HP:0004308) | 2.34039940 |
| 69 | Muscle stiffness (HP:0003552) | 2.32850107 |
| 70 | Abnormality of the dental root (HP:0006486) | 2.32403671 |
| 71 | Taurodontia (HP:0000679) | 2.32403671 |
| 72 | Abnormality of permanent molar morphology (HP:0011071) | 2.32403671 |
| 73 | Supraventricular tachycardia (HP:0004755) | 2.31746586 |
| 74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31204317 |
| 75 | Supraventricular arrhythmia (HP:0005115) | 2.30307066 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.29144133 |
| 77 | Syncope (HP:0001279) | 2.27290971 |
| 78 | Abnormality of secondary sexual hair (HP:0009888) | 2.26334567 |
| 79 | Abnormality of the axillary hair (HP:0100134) | 2.26334567 |
| 80 | Hypoplastic pelvis (HP:0008839) | 2.21166826 |
| 81 | Astrocytoma (HP:0009592) | 2.20361106 |
| 82 | Abnormality of the astrocytes (HP:0100707) | 2.20361106 |
| 83 | Abnormal blistering of the skin (HP:0008066) | 2.19803783 |
| 84 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17347308 |
| 85 | Polar cataract (HP:0010696) | 2.17200115 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.17013261 |
| 87 | Woolly hair (HP:0002224) | 2.15921788 |
| 88 | Nail dystrophy (HP:0008404) | 2.15820454 |
| 89 | Hypoplasia of the iris (HP:0007676) | 2.13861926 |
| 90 | Asymmetric septal hypertrophy (HP:0001670) | 2.13712211 |
| 91 | Split foot (HP:0001839) | 2.11330949 |
| 92 | Rectal prolapse (HP:0002035) | 2.10318991 |
| 93 | Bundle branch block (HP:0011710) | 2.10318690 |
| 94 | Abnormality of molar morphology (HP:0011070) | 2.08702896 |
| 95 | Abnormality of molar (HP:0011077) | 2.08702896 |
| 96 | Round ear (HP:0100830) | 2.08521983 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.08108258 |
| 98 | Distal arthrogryposis (HP:0005684) | 2.07980925 |
| 99 | Frequent falls (HP:0002359) | 2.07096954 |
| 100 | Palmoplantar keratoderma (HP:0000982) | 2.04143411 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 2.03136523 |
| 102 | Nephritis (HP:0000123) | 2.02528653 |
| 103 | Dysmetric saccades (HP:0000641) | 2.02306794 |
| 104 | Abnormality of the dental pulp (HP:0006479) | 2.01911200 |
| 105 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01116430 |
| 106 | Pterygium (HP:0001059) | 2.01046304 |
| 107 | Pustule (HP:0200039) | 2.00525571 |
| 108 | Hyperkalemia (HP:0002153) | 2.00468407 |
| 109 | Atrioventricular block (HP:0001678) | 1.99623242 |
| 110 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99295660 |
| 111 | Confusion (HP:0001289) | 1.98670451 |
| 112 | Broad metatarsal (HP:0001783) | 1.97394994 |
| 113 | Mixed hearing impairment (HP:0000410) | 1.96818377 |
| 114 | Neck muscle weakness (HP:0000467) | 1.96277016 |
| 115 | Increased IgE level (HP:0003212) | 1.96014299 |
| 116 | Paralysis (HP:0003470) | 1.94909095 |
| 117 | Increased density of long bones (HP:0006392) | 1.93808534 |
| 118 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.93493415 |
| 119 | Lip pit (HP:0100267) | 1.91779798 |
| 120 | Nasolacrimal duct obstruction (HP:0000579) | 1.91153376 |
| 121 | Aplasia cutis congenita (HP:0001057) | 1.90832311 |
| 122 | Myotonia (HP:0002486) | 1.90265095 |
| 123 | Areflexia of lower limbs (HP:0002522) | 1.89917739 |
| 124 | Biliary tract neoplasm (HP:0100574) | 1.89746725 |
| 125 | Flat acetabular roof (HP:0003180) | 1.89008757 |
| 126 | Abnormal hair laboratory examination (HP:0003328) | 1.87571848 |
| 127 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87234148 |
| 128 | Abnormality of the labia majora (HP:0012881) | 1.86792029 |
| 129 | Follicular hyperkeratosis (HP:0007502) | 1.86518486 |
| 130 | Abnormal atrioventricular conduction (HP:0005150) | 1.86478080 |
| 131 | Ureteral stenosis (HP:0000071) | 1.86245746 |
| 132 | Abnormality of incisor morphology (HP:0011063) | 1.85882816 |
| 133 | Esophageal varix (HP:0002040) | 1.84490408 |
| 134 | Parakeratosis (HP:0001036) | 1.84478127 |
| 135 | Heart block (HP:0012722) | 1.83627008 |
| 136 | Shallow orbits (HP:0000586) | 1.83399971 |
| 137 | Aneurysm (HP:0002617) | 1.83222480 |
| 138 | Skin pits (HP:0100276) | 1.82865426 |
| 139 | Conical tooth (HP:0000698) | 1.82706405 |
| 140 | Scapular winging (HP:0003691) | 1.82362349 |
| 141 | Hypoplastic labia majora (HP:0000059) | 1.81357168 |
| 142 | Abnormality of sodium homeostasis (HP:0010931) | 1.80984341 |
| 143 | Achilles tendon contracture (HP:0001771) | 1.79312040 |
| 144 | Abnormality of proline metabolism (HP:0010907) | 1.78403543 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.78403543 |
| 146 | Fused cervical vertebrae (HP:0002949) | 1.78402064 |
| 147 | Cholecystitis (HP:0001082) | 1.76361789 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 1.76361789 |
| 149 | Ankle contracture (HP:0006466) | 1.74131579 |
| 150 | Fragile skin (HP:0001030) | 1.72759146 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.71876045 |
| 152 | Cerebral aneurysm (HP:0004944) | 1.71844749 |
| 153 | Ventricular fibrillation (HP:0001663) | 1.71803681 |
| 154 | Abnormality of the neuromuscular junction (HP:0003398) | 1.71722056 |
| 155 | Acanthocytosis (HP:0001927) | 1.71445569 |
| 156 | Intrahepatic cholestasis (HP:0001406) | 1.70994923 |
| 157 | Ectropion (HP:0000656) | 1.70667031 |
| 158 | Increased serum pyruvate (HP:0003542) | 1.70300484 |
| 159 | Abnormality of the lacrimal duct (HP:0011481) | 1.70041862 |
| 160 | Alopecia of scalp (HP:0002293) | 1.69575708 |
| 161 | Abnormality of the gastric mucosa (HP:0004295) | 1.69251895 |
| 162 | Sudden cardiac death (HP:0001645) | 1.68529992 |
| 163 | Slender build (HP:0001533) | 1.67843476 |
| 164 | Reticulocytosis (HP:0001923) | 1.67749865 |
| 165 | Curly hair (HP:0002212) | 1.65156490 |
| 166 | Spinal rigidity (HP:0003306) | 1.64523147 |
| 167 | Ureteral obstruction (HP:0006000) | 1.63789212 |
| 168 | Facial diplegia (HP:0001349) | 1.62542181 |
| 169 | Interstitial pulmonary disease (HP:0006530) | 1.61742374 |
| 170 | Fatigable weakness (HP:0003473) | 1.60647149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 5.21682106 |
| 2 | EPHA2 | 4.29472343 |
| 3 | TRIB3 | 3.86933015 |
| 4 | EEF2K | 3.49456508 |
| 5 | TTN | 3.47851156 |
| 6 | PBK | 3.21615676 |
| 7 | STK39 | 2.68101321 |
| 8 | EPHB1 | 2.33575318 |
| 9 | RIPK1 | 2.25422285 |
| 10 | MATK | 2.18731383 |
| 11 | FLT3 | 2.06887288 |
| 12 | TNIK | 1.93620905 |
| 13 | SIK1 | 1.85069571 |
| 14 | PTK6 | 1.84463630 |
| 15 | NEK1 | 1.80164854 |
| 16 | EPHA4 | 1.77915370 |
| 17 | LATS2 | 1.66610604 |
| 18 | OBSCN | 1.65777644 |
| 19 | ERN1 | 1.62887677 |
| 20 | ACVR1B | 1.62867510 |
| 21 | DMPK | 1.60382456 |
| 22 | FGFR4 | 1.59575266 |
| 23 | STK10 | 1.58626391 |
| 24 | MET | 1.58328659 |
| 25 | LRRK2 | 1.57685471 |
| 26 | LMTK2 | 1.54181713 |
| 27 | BCR | 1.51593980 |
| 28 | RPS6KB2 | 1.50171381 |
| 29 | PIK3CA | 1.45358853 |
| 30 | MAP2K3 | 1.45203963 |
| 31 | NTRK1 | 1.43226025 |
| 32 | MOS | 1.42405298 |
| 33 | STK38L | 1.40977207 |
| 34 | EPHA3 | 1.39883392 |
| 35 | MUSK | 1.37300578 |
| 36 | MAP3K10 | 1.33055229 |
| 37 | NME2 | 1.31811161 |
| 38 | WEE1 | 1.30572170 |
| 39 | TRIM28 | 1.30145673 |
| 40 | PDK4 | 1.27433324 |
| 41 | PDK3 | 1.27433324 |
| 42 | MAP3K7 | 1.24977924 |
| 43 | BMX | 1.24119218 |
| 44 | BRSK2 | 1.22841475 |
| 45 | MAP3K3 | 1.19875149 |
| 46 | FER | 1.15481487 |
| 47 | MAP3K9 | 1.13870674 |
| 48 | ROCK2 | 1.12860525 |
| 49 | MAPKAPK5 | 1.12689255 |
| 50 | MAP4K1 | 1.11947776 |
| 51 | SGK223 | 1.11277346 |
| 52 | SGK494 | 1.11277346 |
| 53 | MAPKAPK3 | 1.10673588 |
| 54 | EIF2AK3 | 1.10562282 |
| 55 | MST4 | 1.08366065 |
| 56 | MST1R | 1.08067745 |
| 57 | FGFR1 | 1.07814392 |
| 58 | MAP3K6 | 1.07643352 |
| 59 | TRPM7 | 1.06285832 |
| 60 | WNK4 | 1.02368007 |
| 61 | EIF2AK1 | 1.01548238 |
| 62 | OXSR1 | 1.01227067 |
| 63 | PAK4 | 0.96779011 |
| 64 | JAK3 | 0.94475120 |
| 65 | STK24 | 0.94082508 |
| 66 | INSRR | 0.93633477 |
| 67 | CAMK2B | 0.93380297 |
| 68 | BCKDK | 0.92189764 |
| 69 | PHKG2 | 0.91315659 |
| 70 | PHKG1 | 0.91315659 |
| 71 | PTK2 | 0.90161569 |
| 72 | LATS1 | 0.89956624 |
| 73 | CAMK2D | 0.89751623 |
| 74 | CDK6 | 0.89547292 |
| 75 | ARAF | 0.89541147 |
| 76 | CASK | 0.89516929 |
| 77 | TTK | 0.86819071 |
| 78 | FGFR3 | 0.85380929 |
| 79 | MAP3K8 | 0.84472164 |
| 80 | EPHB2 | 0.84327000 |
| 81 | ILK | 0.84019897 |
| 82 | TAOK1 | 0.83939335 |
| 83 | TIE1 | 0.82787938 |
| 84 | PDGFRA | 0.82192765 |
| 85 | NEK6 | 0.80669729 |
| 86 | TYK2 | 0.80436672 |
| 87 | NME1 | 0.80025985 |
| 88 | MKNK1 | 0.79892697 |
| 89 | ALK | 0.79643680 |
| 90 | RET | 0.78935941 |
| 91 | GRK6 | 0.78506691 |
| 92 | MAP3K11 | 0.77093581 |
| 93 | CDK12 | 0.74262259 |
| 94 | ZAP70 | 0.73340871 |
| 95 | ROCK1 | 0.71333297 |
| 96 | MYLK | 0.68368767 |
| 97 | CDK4 | 0.67351270 |
| 98 | RPS6KA4 | 0.67194881 |
| 99 | PRKCE | 0.65932476 |
| 100 | ERBB2 | 0.65790803 |
| 101 | FRK | 0.62223287 |
| 102 | PIM2 | 0.61568584 |
| 103 | ITK | 0.61200020 |
| 104 | MKNK2 | 0.60852989 |
| 105 | TGFBR1 | 0.60644407 |
| 106 | NLK | 0.60178148 |
| 107 | PLK2 | 0.58001599 |
| 108 | BMPR1B | 0.56928373 |
| 109 | MAP2K2 | 0.56783958 |
| 110 | PAK2 | 0.56654767 |
| 111 | MAP3K12 | 0.56397820 |
| 112 | JAK2 | 0.56230331 |
| 113 | MTOR | 0.55586336 |
| 114 | NEK9 | 0.54871301 |
| 115 | ERBB3 | 0.54028079 |
| 116 | MAP3K1 | 0.52946470 |
| 117 | PIM1 | 0.52530502 |
| 118 | NTRK2 | 0.51790502 |
| 119 | TBK1 | 0.50896581 |
| 120 | MAP3K5 | 0.50133981 |
| 121 | MAPK11 | 0.49520828 |
| 122 | KSR2 | 0.48541230 |
| 123 | PAK3 | 0.48293109 |
| 124 | CAMK2A | 0.46950025 |
| 125 | PRKD1 | 0.46176919 |
| 126 | CAMK2G | 0.45566735 |
| 127 | PLK4 | 0.45449298 |
| 128 | SCYL2 | 0.45419582 |
| 129 | GRK5 | 0.45031125 |
| 130 | PDGFRB | 0.45021418 |
| 131 | JAK1 | 0.44912043 |
| 132 | AKT2 | 0.43829286 |
| 133 | HCK | 0.43080684 |
| 134 | PRKAA2 | 0.42202770 |
| 135 | STK4 | 0.42019127 |
| 136 | RPS6KA1 | 0.40544678 |
| 137 | PIK3CG | 0.40148092 |
| 138 | BTK | 0.39759311 |
| 139 | MAPKAPK2 | 0.39674169 |
| 140 | MAP3K2 | 0.39489617 |
| 141 | PINK1 | 0.39315277 |
| 142 | PDK2 | 0.39313638 |
| 143 | STK3 | 0.38360561 |
| 144 | MAP2K1 | 0.37159654 |
| 145 | DAPK3 | 0.36855078 |
| 146 | EGFR | 0.36770434 |
| 147 | TESK1 | 0.36463234 |
| 148 | NEK2 | 0.36221824 |
| 149 | IGF1R | 0.36156149 |
| 150 | PKN1 | 0.35528351 |
| 151 | GRK1 | 0.33864792 |
| 152 | TSSK6 | 0.31244787 |
| 153 | MAPK15 | 0.30167006 |
| 154 | SRPK1 | 0.29679996 |
| 155 | PRKG2 | 0.29111475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.21572417 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.97955018 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.62954922 |
| 4 | Carbon metabolism_Homo sapiens_hsa01200 | 2.45325199 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43551350 |
| 6 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.42965276 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.30188053 |
| 8 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.23987778 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23163523 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14713766 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.13488726 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.08972888 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.08839235 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00207709 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.91563742 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 1.83831022 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83452956 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.79438767 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.76864849 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73300774 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.70254400 |
| 22 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.68346413 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65981323 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61073636 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60979913 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.57848589 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.57446422 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52764955 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52115231 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51687798 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.49751487 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46620614 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40976572 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.39929656 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39303706 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38601467 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36081788 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.33468239 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28929685 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.26732138 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.26708193 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25524604 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25073736 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24450563 |
| 45 | Mineral absorption_Homo sapiens_hsa04978 | 1.23928158 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20716016 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18742077 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16709433 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14372286 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12105347 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10946913 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09247710 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08347218 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06948098 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06301466 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05773231 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05012285 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02056829 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01041088 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00893763 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.98991353 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96448628 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93309658 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92219169 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91304161 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91222960 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90638858 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89834177 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.89596258 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87838705 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87827257 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86530496 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85755979 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84066064 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84030931 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80797553 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80412141 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78818341 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77765253 |
| 80 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75121560 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74003279 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73057296 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72539808 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71520139 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70769826 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70469444 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69905982 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69860805 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69789883 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69206691 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69105933 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.68795257 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.68271626 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66125312 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64360173 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64254477 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.64123220 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60574537 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58123459 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56179152 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55720044 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55400789 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54471487 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53569548 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.52838326 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51952780 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51145458 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49767991 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48970195 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48815863 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48758679 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48127143 |
| 113 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48069562 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47245648 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46324049 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.45766966 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44949690 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.44760904 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44554873 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44444642 |
| 121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44431119 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44190102 |
| 123 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.44049524 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43421464 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42722793 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42292749 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42246824 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.41552517 |
| 129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40611904 |
| 130 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39752914 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.38817663 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38657257 |
| 133 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38060127 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37874420 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.37625905 |
| 136 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37408345 |
| 137 | Salmonella infection_Homo sapiens_hsa05132 | 0.36555188 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35246255 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35210414 |
| 140 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34591066 |
| 141 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34141402 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34088126 |
| 143 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33465456 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32876735 |
| 145 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32459788 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.31643040 |
| 147 | Melanogenesis_Homo sapiens_hsa04916 | 0.30936971 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30303517 |
| 149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30290044 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.30183764 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29866330 |
| 152 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29511609 |
| 153 | Long-term depression_Homo sapiens_hsa04730 | 0.28887227 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28430794 |
| 155 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26480698 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26445597 |

